Peppermint earns respect in mainstream medicine
April 19, 2011 in Medications
Peppermint is now clinically proven to be an effective pain reliever for Irritable Bowel Syndrome. Photo by Hajnalka Ardai, iStock Photos.
University of Adelaide researchers have shown for the first time how peppermint helps to relieve Irritable Bowel Syndrome, which affects up to 20% of the population.
In a paper published this week in the international journal Pain, researchers from the University's Nerve-Gut Research Laboratory explain how peppermint activates an "anti-pain" channel in the colon, soothing inflammatory pain in the gastrointestinal tract.
Dr Stuart Brierley says while peppermint has been commonly prescribed by naturopaths for many years, there has been no clinical evidence until now to demonstrate why it is so effective in relieving pain.
"Our research shows that peppermint acts through a specific anti-pain channel called TRPM8 to reduce pain sensing fibres, particularly those activated by mustard and chilli. This is potentially the first step in determining a new type of mainstream clinical treatment for Irritable Bowel Syndrome (IBS)," he says.
IBS is a gastrointestinal disorder, causing abdominal pain, bloating, diarrhoea and/or constipation. It affects about 20% of Australians and costs millions of dollars each year in lost productivity, work absenteeism and health care.
"This is a debilitating condition and affects many people on a daily basis, particularly women who are twice as likely to experience Irritable Bowel Syndrome," Dr Brierley says.
"Some people find their symptoms appear after consuming fatty and spicy foods, coffee and alcohol, but it is more complex than that. There appears to be a definite link between IBS and a former bout of gastroenteritis, which leaves nerve pain fibres in a heightened state, altering mechanisms in the gut wall and resulting in ongoing pain."
Dr Brierley says the recent floods in Queensland and Victoria could result in a spike of gastroenteritis cases in Australia due to the contamination of some water supplies in affected regions.
He said case studies in Europe and Canada showed that many people who contracted gastroenteritis from contaminated water supplies went on to experience IBS symptoms that persisted for at least eight years.
There is no cure for IBS and it often comes and goes over a person's lifetime.
Apart from gastroenteritis and food intolerance, IBS can be brought on by food poisoning, stress, a reaction to antibiotics, and in some cases is genetic.
More information: http://www.elsevie … #description
Provided by
University of Adelaide
-
Common bowel problem linked to chili pepper pain receptor
Jun 10, 2008 |
not rated yet |
0
-
Allergic disease linked to irritable bowel syndrome
Jan 30, 2008 |
not rated yet |
0
-
FDA OKs Amitiza for treatment of IBS-C
Apr 30, 2008 |
not rated yet |
0
-
The overlap in gastroesophageal reflux disorder and irritable bowel syndrome
Apr 01, 2010 |
not rated yet |
0
-
Patients with Irritable Bowel Syndrome not more likely to develop polyps, colon cancer
Mar 09, 2010 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (42) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
A couple of questions about schizophrenia
May 17, 2012
-
Paralyzed woman uses thoughts to move robotic arm
May 17, 2012
-
Coffee Decreases Risk of Death
May 17, 2012
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
- More from Physics Forums - Medical Sciences
More news stories
Generic versions of plavix approved
(HealthDay) -- The first generic versions of Plavix (clopidogrel bisulfate) have been approved by the U.S. Food and Drug Administration.
Medications
May 18, 2012 |
not rated yet |
0
'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs
Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published ...
Medications
May 16, 2012 |
not rated yet |
0
Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...
Medications
May 16, 2012 |
not rated yet |
0
|
In drug-approval race, US FDA ahead of Canada, Europe
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...
Medications
May 16, 2012 |
not rated yet |
0
|
Too many drugs for many older patients
Older patients are increasingly prescribed multiple drugs that, when combined, can lead to negative side effects and poor health outcomes. A new Cochrane Library evidence review reveals that little is kno ...
Medications
May 16, 2012 |
not rated yet |
0
Growth factor in stem cells may spur recovery from multiple sclerosis
A substance in human mesenchymal stem cells that promotes growth appears to spur restoration of nerves and their function in rodent models of multiple sclerosis (MS), researchers at Case Western Reserve University School ...
Use of in-hospital mortality to assess ICU performance may bias quality measurement
In-hospital mortality for ICU patients is often used as a quality measure, but discharge practices may bias results in a way that disadvantages large academic hospitals, according to a recently conducted study.
Biomarker predicts response to cancer treatment
VIB researcher Diether Lambrechts, associated with KU Leuven, has discovered a biomarker that might potentially predict which patients will benefit more from treatment with bevacizumab (Avastin). If validated, this discovery ...
Heparin-like compounds inhibit breast cancer metastasis to bone
Researchers from VTT Technical Research Centre of Finland have in collaboration with the University of Turku, Indiana University and two Finnish companies, Biotie Therapies Corp. and Pharmatest Services Ltd, discovered a ...
Stopping cell migration may help block fibrosis and the spread of cancer
(Medical Xpress) -- Discoveries by a Yale-led team of scientists could lead the way for development of new therapies for treating fibrosis and tumor metastasis. The researchers have both uncovered a signaling ...
New drug shrinks brain tumours in melanoma patients
(Medical Xpress) -- Australian researchers have reported promising results with a new drug that shrinks brain tumours in melanoma patients. Their findings are published in The Lancet medical journal today. ...
Apr 19, 2011
Rank: not rated yet